Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

Similar documents
2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2017 Step Therapy (ST) Criteria

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

Drugs That Require Step Therapy (ST) Step Therapy Medications

2018 Step Therapy (ST) Criteria

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

2019 STEP THERAPY CRITERIA UCare Connect + Medicare (SNBC) (HMO SNP) UCare s Minnesota Senior Health Options (MSHO) (HMO SNP)

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

2018 WPS MedicareRx Plan (PDP) Step Therapy

Step Therapy Requirements

Step Therapy Requirements

2018 STEP THERAPY CRITERIA UCare Connect + Medicare (SNBC) (HMO SNP) UCare s Minnesota Senior Health Options (MSHO) (HMO SNP)

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

2019 Step Therapy (ST) Criteria

2019 Simply Step Therapy Document

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

Drugs That Require Step Therapy (ST)

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

ANTICONVULSANT THERAPY

ALZHEIMER'S DRUGS. Details. Step 2: Exelon Patch 13.3 mg/24 hour transdermal Exelon Patch 4.6 mg/24 hr transdermal

Step Therapy Medications

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST)

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

2018 Step Therapy Criteria (List of Step Therapy Criteria)

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2018 Step Therapy Criteria (List of Step Therapy Criteria)

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Step Therapy Criteria

These medications will require preauthorization (PA) for HMSA Medicare Part D members.

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE

Step Therapy Criteria 2019

ALLERGIC CONJUNCTIVITIS AGENTS

2016 Step Therapy (ST) Criteria

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Step Therapy Requirements. Effective: 11/01/2018

SmithRx Standard Formulary Step Therapy List

ANTICONVULSANT STEP THERAPY

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

ATYPICAL ANTIPSYCHOTICS

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ALLERGIC RHINITIS-NASAL

Cigna Drug and Biologic Coverage Policy

Step Therapy Requirements. Effective: 05/01/2018

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Step Therapy Information... 4 Prior Authorization Information ACE Inhibitors and ACE Inhibitor Combinations...60 Acne Therapy...

2018 GRS Premier Step Therapy Document. September 2018 Y0114_18_33177_I_010

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Quarterly pharmacy formulary change notice

ANGIOTENSIN RECEPTOR BLOCKERS

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

2013 Step Therapy (ST) Criteria

2019 GRS Premier Step Therapy Document

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Quarterly pharmacy formulary change notice

Texas Prior Authorization Program Clinical Edit Criteria

Quarterly pharmacy formulary change

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

2015 Step Therapy (ST) Criteria

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

Texas Prior Authorization Program Clinical Edit Criteria

Medication and Dose 10/04/ /05/2016 Total % Change Since 10/2012 ABILIFY 10 MG TABLET $18.76 $ %

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 Step Therapy FID 18088

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

Transcription:

CHRISTUS Health Plan Generations (HMO) 2017 Step Therapy Criteria H1189_PC57 Accepted 11/17/2016 1

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6 OPHTHALMIC PROSTAGLANDINS-PST... 7 ORAL BISPHOSPHONATES... 8 RAPID-ACTING INSULIN-PST... 9 TOPICAL ACTINIC KERATOSIS-PST... 10 ULORIC... 11 INDEX. 12 2

ALPHA BLOCKERS alfuzosin ER 10 mg tablet,extended release 24 hr doxazosin 1 mg tablet doxazosin 2 mg tablet doxazosin 4 mg tablet doxazosin 8 mg tablet tamsulosin 0.4 mg capsule terazosin 1 mg capsule terazosin 10 mg capsule terazosin 2 mg capsule terazosin 5 mg capsule Rapaflo 4 mg capsule Rapaflo 8 mg capsule drug may be given. 3

COLCRYS-PST Mitigare 0.6 mg capsule Colcrys 0.6 mg tablet Criteria If the patient has tried one Step 1 product, authorization for a Step 2 product may be given. Exceptions can be made for a step 2 drug (without a trial of a step 1 drug) for the treatment of Familial Mediterranean Fever and for the treatment of gout flares (i.e, prophylaxis of gout flares requires a trial of a step 1 drug). 4

DPP-4 INHIBITORS-PST Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Janumet XR 100 mg-1,000 mg tablet,extended release Janumet XR 50 mg-1,000 mg tablet,extended release Janumet XR 50 mg-500 mg tablet,extended release Januvia 100 mg tablet Januvia 25 mg tablet Jentadueto 2.5 mg-1,000 mg tablet Jentadueto 2.5 mg-500 mg tablet Jentadueto 2.5 mg-850 mg tablet Jentadueto XR 2.5 mg-1,000 mg tablet, extended release Jentadueto XR 5 mg-1,000 mg tablet, extended release Januvia 50 mg tablet Kombiglyze XR 2.5 mg-1,000 mg tablet,extended release Kombiglyze XR 5 mg-1,000 mg tablet,extended release Kombiglyze XR 5 mg-500 mg tablet,extended release Onglyza 2.5 mg tablet Onglyza 5 mg tablet Kazano 12.5 mg-1,000 mg tablet Kazano 12.5 mg-500 mg tablet Nesina 12.5 mg tablet Nesina 25 mg tablet Nesina 6.25 mg tablet Tradjenta 5 mg tablet drug may be given. 5

HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS Rozerem 8 mg tablet trazodone 100 mg tablet trazodone 150 mg tablet eszopiclone 1 mg tablet eszopiclone 2 mg tablet eszopiclone 3 mg tablet zaleplon 10 mg capsule zaleplon 5 mg capsule zolpidem 10 mg tablet trazodone 300 mg tablet trazodone 50 mg tablet zolpidem 5 mg tablet zolpidem ER 12.5 mg tablet,extended release,multiphase zolpidem ER 6.25 mg tablet,extended release,multiphase drug may be given. This step therapy program applies to patients greater than 64 years of age only.authorization for a step 2 drug may be given in patients aged less than 65 years. Prior to approval of a step 2 drug, the physician must have assessed risk versus benefit in prescribing the requested HRM for the patient and must confirm that he/she would still like to initiate/continue therapy. 6

OPHTHALMIC PROSTAGLANDINS-PST bimatoprost 0.03 % eye drops latanoprost 0.005 % eye drops Lumigan 0.01 % eye drops Travatan Z 0.004 % eye drops travoprost (benzalkonium) 0.004 % eye drops Zioptan (PF) 0.0015 % eye drops in a dropperette drug may be given. Authorization for Zioptan may be given if the patient has a known benzalkonium chloride (BAK) sensitivity or a known sensitivity to other ophthalmic preservatives. 7

ORAL BISPHOSPHONATES alendronate 10 mg tablet alendronate 35 mg tablet alendronate 40 mg tablet alendronate 5 mg tablet alendronate 70 mg tablet alendronate 70 mg/75 ml oral solution ibandronate 150 mg tablet risedronate 150 mg tablet risedronate 30 mg tablet risedronate 35 mg tablet risedronate 35 mg tablet (12 pack) risedronate 35 mg tablet (4 pack) risedronate 35 mg tablet,delayed release risedronate 5 mg tablet Fosamax Plus D 70 mg-2,800 unit tablet Fosamax Plus D 70 mg-5,600 unit tablet drug may be given. 8

RAPID-ACTING INSULIN-PST Humalog 100 unit/ml subcutaneous cartridge Humalog 100 unit/ml subcutaneous solution Humalog KwikPen 100 unit/ml subcutaneous Humalog KwikPen 200 unit/ml (3 ml) subcutaneous Apidra 100 unit/ml subcutaneous solution Apidra SoloStar 100 unit/ml subcutaneous insulin pen Novolog 100 unit/ml subcutaneous solution Novolog Flexpen 100 unit/ml subcutaneous Humalog Mix 50-50 100 unit/ml subcutaneous suspension Humalog Mix 50-50 KwikPen 100 unit/ml subcutaneous pen Humalog Mix 75-25 100 unit/ml subcutaneous suspension Humalog Mix 75-25 KwikPen 100 unit/ml subcutaneous insulin pen Novolog Mix 70-30 100 unit/ml subcutaneous solution Novolog Mix 70-30 FlexPen 100 unit/ml subcutaneous pen Novolog PenFill 100 unit/ml subcutaneous cartridge drug may be given. 9

TOPICAL ACTINIC KERATOSIS-PST Carac 0.5 % topical cream diclofenac 3 % topical gel fluorouracil 2 % topical solution fluorouracil 5 % topical cream fluorouracil 0.5 % topical cream Zyclara 2.5 % topical cream pump fluorouracil 5 % topical solution imiquimod 5 % topical cream packet Picato 0.015 % topical gel Picato 0.05 % topical gel Zyclara 3.75 % topical cream packet drug may be given. 10

ULORIC allopurinol 100 mg tablet allopurinol 300 mg tablet Uloric 40 mg tablet Uloric 80 mg tablet drug may be given. Authorization may be given for Uloric if the patient has renal insufficiency or decreased renal function. Authorization may be given for Uloric if the patient is receiving concomitant medications that have significant drug-drug interactions with allopurinol, which are not noted with Uloric (eg, cyclosporine, chlorpropamide). 11

Index A alendronate 10 mg tablet... 8 alendronate 35 mg tablet... 8 alendronate 40 mg tablet... 8 alendronate 5 mg tablet... 8 alendronate 70 mg tablet... 8 alendronate 70 mg/75 ml oral solution... 8 alfuzosin ER 10 mg tablet,extended release 24 hr... 3 allopurinol 100 mg tablet... 11 allopurinol 300 mg tablet... 11 Apidra 100 unit/ml subcutaneous solution 9 Apidra SoloStar 100 unit/ml subcutaneous insulin pen... 9 B bimatoprost 0.03 % eye drops... 7 C Carac 0.5 % topical cream... 10 Colcrys 0.6 mg tablet... 4 D diclofenac 3 % topical gel... 10 doxazosin 1 mg tablet... 3 doxazosin 2 mg tablet... 3 doxazosin 4 mg tablet... 3 doxazosin 8 mg tablet... 3 E eszopiclone 1 mg tablet... 6 eszopiclone 2 mg tablet... 6 eszopiclone 3 mg tablet... 6 F fluorouracil 0.5 % topical cream... 10 fluorouracil 2 % topical solution... 10 fluorouracil 5 % topical cream... 10 fluorouracil 5 % topical solution... 10 Fosamax Plus D 70 mg-2,800 unit tablet... 8 Fosamax Plus D 70 mg-5,600 unit tablet... 8 H Humalog 100 unit/ml subcutaneous cartridge... 9 Humalog 100 unit/ml subcutaneous solution... 9 Humalog KwikPen 100 unit/ml subcutaneous... 9 Humalog KwikPen 200 unit/ml (3 ml) subcutaneous... 9 Humalog Mix 50-50 100 unit/ml subcutaneous suspension... 9 Humalog Mix 50-50 KwikPen 100 unit/ml subcutaneous pen... 9 Humalog Mix 75-25 100 unit/ml subcutaneous suspension... 9 Humalog Mix 75-25 KwikPen 100 unit/ml subcutaneous insulin pen... 9 I ibandronate 150 mg tablet... 8 imiquimod 5 % topical cream packet... 10 J Janumet 50 mg-1,000 mg tablet... 5 Janumet 50 mg-500 mg tablet... 5 Janumet XR 100 mg-1,000 mg tablet,extended release... 5 Janumet XR 50 mg-1,000 mg tablet,extended release... 5 Janumet XR 50 mg-500 mg tablet,extended release... 5 Januvia 100 mg tablet... 5 Januvia 25 mg tablet... 5 Januvia 50 mg tablet... 5 Jentadueto 2.5 mg-1,000 mg tablet... 5 Jentadueto 2.5 mg-500 mg tablet... 5 Jentadueto 2.5 mg-850 mg tablet... 5 Jentadueto XR 2.5 mg-1,000 mg tablet, extended release... 5 Jentadueto XR 5 mg-1,000 mg tablet, extended release... 5 K Kazano 12.5 mg-1,000 mg tablet... 5 Kazano 12.5 mg-500 mg tablet... 5 Kombiglyze XR 2.5 mg-1,000 mg tablet,extended release... 5 Kombiglyze XR 5 mg-1,000 mg tablet,extended release... 5 Kombiglyze XR 5 mg-500 mg tablet,extended release... 5 L latanoprost 0.005 % eye drops... 7 Lumigan 0.01 % eye drops... 7 12

M Mitigare 0.6 mg capsule... 4 N Nesina 12.5 mg tablet... 5 Nesina 25 mg tablet... 5 Nesina 6.25 mg tablet... 5 Novolog 100 unit/ml subcutaneous solution... 9 Novolog Flexpen 100 unit/ml subcutaneous... 9 Novolog Mix 70-30 100 unit/ml subcutaneous solution... 9 Novolog Mix 70-30 FlexPen 100 unit/ml subcutaneous pen... 9 Novolog PenFill 100 unit/ml subcutaneous cartridge... 9 O Onglyza 2.5 mg tablet... 5 Onglyza 5 mg tablet... 5 P Picato 0.015 % topical gel... 10 Picato 0.05 % topical gel... 10 R Rapaflo 4 mg capsule... 3 Rapaflo 8 mg capsule... 3 risedronate 150 mg tablet... 8 risedronate 30 mg tablet... 8 risedronate 35 mg tablet... 8 risedronate 35 mg tablet (12 pack)... 8 risedronate 35 mg tablet (4 pack)... 8 risedronate 35 mg tablet,delayed release... 8 risedronate 5 mg tablet... 8 Rozerem 8 mg tablet... 6 T tamsulosin 0.4 mg capsule... 3 terazosin 1 mg capsule... 3 terazosin 10 mg capsule... 3 terazosin 2 mg capsule... 3 terazosin 5 mg capsule... 3 Tradjenta 5 mg tablet... 5 Travatan Z 0.004 % eye drops... 7 travoprost (benzalkonium) 0.004 % eye drops... 7 trazodone 100 mg tablet... 6 trazodone 150 mg tablet... 6 trazodone 300 mg tablet... 6 trazodone 50 mg tablet... 6 U Uloric 40 mg tablet... 11 Uloric 80 mg tablet... 11 Z zaleplon 10 mg capsule... 6 zaleplon 5 mg capsule... 6 Zioptan (PF) 0.0015 % eye drops in a dropperette... 7 zolpidem 10 mg tablet... 6 zolpidem 5 mg tablet... 6 zolpidem ER 12.5 mg tablet,extended release,multiphase... 6 zolpidem ER 6.25 mg tablet,extended release,multiphase... 6 Zyclara 2.5 % topical cream pump... 10 Zyclara 3.75 % topical cream packet... 10 13